Results 81 to 90 of about 4,732 (172)

Pharmacokinetic and pharmacodynamic properties of cannabigerol in male mice. [PDF]

J Pharmacol Exp Ther
Mabou Tagne A, Ahmed F, Tran A, Galvani F, Debbaneh L, Perranoski ER, Sarlah D, Das A, Pabon E, Cooper Z, Piomelli D.   +10 more
europepmc   +1 more source

Quinacrine and rimonabant prolong the life span of Caenorhabditis elegans. [PDF]

Geroscience
He Q, Guo S, Zhou A, Gong X, Cheng W, Ren H.   +5 more
europepmc   +1 more source

Modulatory Effects of CB1 Receptors on Cognitive Performance in Rat Model of Empathic Pain. [PDF]

Basic Clin Neurosci
Rahimi Shourmasti F, Rafaiee R, Seyedhosseini Tamijani SM, Khodamoradi M, Shabani M, Ghazvini H.   +5 more
europepmc   +1 more source

Topical WIN 55 212-2 Confers Long-Term Intraocular Pressure-Independent Neuroprotection in the DBA/2J Mouse Model of Glaucoma. [PDF]

Ophthalmol Sci
Gallo Afflitto G, Chou TH, Korsch ML, Aiello F, Adornetto A, Russo R, Bagetta G, Nucci C, Porciatti V.   +8 more
europepmc   +1 more source

Pharmacotherapy for Cannabis Use Disorder: Preclinical and Clinical Models. [PDF]

Curr Top Behav Neurosci
Bedillion MF, Moore CF, Weerts EM, Arout CA, Harris HM, Haney M.   +5 more
europepmc   +1 more source

Diet-dependent modulation of energy balance by CB1 signaling in peripheral sensory neurons. [PDF]

iScience
Linden B, Herz H, Jarrah M, Tasabehji D, Saleh S, Fraer A, Clark P, Ye Y, Chu Y, Al-Khalil Z, Morgan DA, Zhu Z, Castorena CM, Zingman L, Rahmouni K, Mokadem M.   +15 more
europepmc   +1 more source

Brain Hsp90 Inhibition Mitigates Facial Allodynia in a Rat Model of CSD Headache and Upregulates Endocannabinoid Signaling in the PAG. [PDF]

Pharmaceuticals (Basel)
Palomino SM, Levine AA, Liktor-Busa E, Tanguturi P, Streicher JM, Largent-Milnes TM.   +5 more
europepmc   +1 more source

Exacerbated cardiac dysfunction from combined alcohol binge and synthetic cannabinoid use. [PDF]

Biomed Pharmacother
Paloczi J, Gunduz-Cinar O, Yokus B, Paes-Leme B, Haskó G, Kunos G, Holmes A, Pacher P.   +7 more
europepmc   +1 more source

<i>Cannabis</i> Medicine 2.0: Nanotechnology-Based Delivery Systems for Synthetic and Chemically Modified Cannabinoids for Enhanced Therapeutic Performance. [PDF]

Nanomaterials (Basel)
Żółnowska I, Gostyńska-Stawna A, Jelińska A, Stawny M.   +3 more
europepmc   +1 more source

Synthesis and Pharmacological Characterization of Novel Peripheral Cannabinoid-1 Receptor Blockers Based on a Tricyclic Scaffold. [PDF]

J Med Chem
Gammal A, Nassar T, Soae Y, Freeman N, Badihi A, Baraghithy S, Nemirovski A, Tam J, Benita S.   +8 more
europepmc   +1 more source